Effectiveness of primary caregiver-mentoring program for the management of schizophrenia at psychiatry out patient department, AIIMS Patna.

Not yet recruiting

• Conditions: Individuals who are the caregiver of patients having schizophrenia.The individual must be providing primary care to the patient, administering medications and living with the patient.

• Registration Number: CTRI/2021/12/038521
• Lead Sponsor: Naveen Kumar Sharma

Brief Summary

The primary caregivers of the schizophrenic patients are the critical link between the patient and management of the treatment outcome. Due to the lack of basic knowledge related to illness and  management of adverse effects of drugs, there is further increase in the load of care on the patient’s primary caregivers and non-adherence to medication of patients. If the caregivers are provided with  knowledge and skills related to management of the patient’s illness, they will be able to provide care independently at their home more efficiently.

Since primary caregiver are playing the pivotal role in management of illness, especially in the medication administration, continuity in treatment of schizophrenic patient will be more effective if caregivers are actively involved in the management of illness and given sufficient knowledge and skills.

Rate of Medication non-adherence is  54.5% very significant in schizophrenic patient and should be considered while planning the treatment. The caregiver-mentoring session can play key role in reducing non-adherence toward medications in schizophrenic patients.

H0 -  There will be no significant difference in medication adherence among experimental group subjects after primary caregiver mentoring program compared to control group subjects as p < 0.05 level of significance.

H1 - There will be significant difference in medication adherence among experimental group subjects after primary caregiver mentoring program compared to control group subjects as p < 0.05 level of significance.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2021-07-12
• Study Start: 2021-12-13

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Caregivers of patients diagnosed with schizophrenia.
• Age group 18 to 58 years old.
• Participants who understands Hindi language.
• Patients who are undergoing antipsychotic drug therapy.

Exclusion Criteria

• Caregivers who are unwilling to participate in the study.
• Caregivers who are already suffering with any psychiatric illness.
• Caregivers who are already attending any psychosocial intervention.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
medication adherence of schizophrenic patients measured by medication adherence rating scale(MARS).	positive score 5 and above signifies adherence to medication measured at an interval of 2 weeks.

Secondary Outcome Measures

Name	Time	Method
1. association between selected sociodemographic variable and effectiveness of primary caregiver-mentoring program for management of schizophrenia.	2. association between effectiveness of primary caregiver-mentoring program and caregiver burden.

Trial Locations

Locations (1)

All India Insititute Of Medical Sciences Patna, Bihar; 🇮🇳 Patna, BIHAR, India

All India Insititute Of Medical Sciences Patna, Bihar

🇮🇳Patna, BIHAR, India

manorama singh gautam

Principal investigator

7987890225

manoramasg@aiimspatna.org